Medical News

RSS

Repros receives US patent for Androxal

Repros Therapeutics Inc. today announced the US Patent and Trademark office has issued U.S. Patent No. 7,759,360 for Androxal, the Company's lead program for the treatment of low testosterone in men. This patent specifically claims methods and materials for the treatment of testosterone deficiency in men with secondary hypogonadism. Repros has over 35 issued or pending US and European patents involving Androxal.

11 Aug 2010

Molecular imaging helps physicians determine patient suitability for ICD therapy

A study published in the August Journal of Nuclear Medicine (JNM) finds that molecular imaging-a non-invasive imaging procedure-can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator (ICD) therapy.

11 Aug 2010

Cramer selects Neolane to support marketing communication programs for clients in healthcare practice

Enterprise marketing software provider Neolane, Inc. today announced that it has been selected by digital marketing and events solution company Cramer to support more effective marketing communications programs for its clients, specifically in its healthcare practice. The first program to benefit from Neolane's comprehensive, flexible marketing automation platform is a Cramer biopharmaceutical client that was seeking to improve the results of an on-going patient communications program that relies on targeted, personalized communications across multiple channels to support patient therapy.

11 Aug 2010

UC Health University Hospital to incorporate MRO's ROI technology with existing EMR system

MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced a contract with UC Health University Hospital (Cincinnati, Ohio) to provide ROI processing services to the facility. Under this agreement, University Hospital will incorporate MRO's ROI technology with its existing electronic medical record system. The new workflow enables the organization to bring its ROI process in-house and partner with MRO to provide the back-office fulfillment functions.

11 Aug 2010

Simple morning walk to school could reduce stress reactivity in children: Study

A simple morning walk to school could reduce stress reactivity in children during the school day, curbing increases in heart rate and blood pressure that can lead to cardiovascular disease later in life, according to a new University at Buffalo study.

11 Aug 2010

OptiNose's bi-directional nasal device delivering fluticasone effective in reducing nasal polyps in CRS patients

OptiNose Inc. announced today that a subgroup analysis of positive Phase II trial results has been published in the July/August issue of the American Journal of Rhinology & Allergy.

11 Aug 2010

Researchers receive $1M grant to train Native American communities improve their health

UC Davis School of Medicine researchers will train Native American communities in Northern California to develop and implement culturally appropriate interventions to improve their health by decreasing obesity and type-2 diabetes, through a $1 million research grant from the National Institute of Diabetes and Kidney Diseases of the National Institutes of Health.

11 Aug 2010

Study shows health care-associated invasive MRSA infections decrease among patients

An analysis of data from 2005 through 2008 of nine metropolitan areas in the U.S. indicates that health care-associated invasive methicillin-resistant Staphylococcus aureus infections decreased among patients with infections that began in the community or in the hospital, according to a study in the August 11 issue of JAMA.

11 Aug 2010

New study refutes common assumptions about consent forms in clinical trials

Although informed consent is an ethical cornerstone in research with humans, some studies suggests that volunteers often do not understand key aspects of the research in which they participate. Recent efforts have been made to improve informed consent by simplifying the consent forms.

11 Aug 2010

PregLem announces exclusive in licensing agreement with Merck Serono for Bentamapimod

PregLem, the Swiss specialty biopharmaceutical company focused on women's reproductive medicine, announces a world-wide, exclusive in licensing agreement for Bentamapimod, a novel, orally active, Jun Kinase Inhibitor from Merck Serono for an undisclosed amount. PregLem will develop the compound for the prevention of post-surgical abdominal adhesions and endometriosis in patients with tubal ligation or comparable effective contraception.

11 Aug 2010

NextGen Healthcare receives ACCME accreditation

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that it has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded accreditation for two years as a provider of continuing medical education for physicians.

11 Aug 2010

Temperature increases could slow rice production, study says

A study published online Monday in Proceedings of the National Academy of Sciences found that anticipated temperature increases "could slow the growth of rice production unless farmers adapt by changing management practices and switch to more heat-tolerant varieties," Reuters reports (Fogarty, 8/10).

11 Aug 2010

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency, Broad Agency Announcement, Defense Sciences Research & Technology to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement.

11 Aug 2010

San Antonio Community Hospital completes system-wide conversion to Masimo rainbow technology

San Antonio Community Hospital in Upland, California, and Masimo, the inventor of Masimo rainbow Pulse CO-Oximetry™, Masimo rainbow Acoustic Monitoring™, and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry, today jointly announced the completion of San Antonio Community Hospital's system-wide conversion to Masimo rainbow technology.

11 Aug 2010

AACN endorses new clinical practice guidelines developed by Renal Physicians Association

The American Association of Critical-Care Nurses (AACN) recently endorsed the clinical practice guideline, "Shared Decision Making in the Appropriate Initiation of and Withdrawal from Dialysis," developed by Renal Physicians Association (RPA), Rockville, Md.

11 Aug 2010

New computerized approach for dental restoration procedures

Oral surgeons may one day have an easier, less costly approach to one important aspect of dental restoration, thanks to a newly patented process developed by researchers at Missouri University of Science and Technology (Missouri S&T).The process computerizes the method for creating a dental bar, also called an over-denture. For dental restoration procedures, the device is the bridge connecting dental implants to dentures.

11 Aug 2010

Silence Therapeutics receives patent for RNA silencing method

Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.

11 Aug 2010

Medical News

Repros receives US patent for Androxal

Molecular imaging helps physicians determine patient suitability for ICD therapy

Cramer selects Neolane to support marketing communication programs for clients in healthcare practice

UC Health University Hospital to incorporate MRO's ROI technology with existing EMR system

Simple morning walk to school could reduce stress reactivity in children: Study

OptiNose's bi-directional nasal device delivering fluticasone effective in reducing nasal polyps in CRS patients

Researchers receive $1M grant to train Native American communities improve their health

Study shows health care-associated invasive MRSA infections decrease among patients

New study refutes common assumptions about consent forms in clinical trials

PregLem announces exclusive in licensing agreement with Merck Serono for Bentamapimod

NextGen Healthcare receives ACCME accreditation

Temperature increases could slow rice production, study says

Medicago USA awarded $21M to develop vaccine facility in Research Triangle Park

San Antonio Community Hospital completes system-wide conversion to Masimo rainbow technology

AACN endorses new clinical practice guidelines developed by Renal Physicians Association

New computerized approach for dental restoration procedures

Silence Therapeutics receives patent for RNA silencing method

Methodist Healthcare System to implement TeleTracking Technologies' RadarFind RTLS

ITI signs NPWT contract with MAGNET

Lutronic second-quarter revenues increase 15% to $11.5 million

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News